United States: NeuExcell Therapeutics Announces $15 Million Series Pre-A+ - Cooley LLP

Investors in the round included Shanghai Zhangjiang Leading Qifan Venture Capital, Jiangxi Jilinxinsheng Enterprise Management, Fujian Haixi Pharmaceuticals, Suzhou Industrial Park Technology Innovation Investment...